Display:
Providers:
Canntab Therapeutics Limited is a Canada-based phytopharmaceutical company. The Company is focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Its hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions. The Company’s operations comprise a single segment engaged in the medical marijuana business. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet. It holds a cannabis standard processing and sales for medical purposes license and a cannabis research license from health Canada.
|
|
|
|
|
November 22, 2022 | ||
---|---|---|
November 21, 2022 | ||
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.